# Business Review Report: "One Health" Architecture Evaluation

## Executive Summary
This report evaluates the current technical architecture of PathoMatch against its stated "One Health" (veterinary and human) dual-market strategy. While there are superficial indicators of multi-species support in the frontend, the core architecture and backend currently fail to support a robust dual-market strategy and present significant risks to efficacy and patient safety.

## Architectural Findings

### 1. Frontend Indicators
The frontend codebase (`SampleUpload.jsx`) includes placeholders indicating support for multiple species (e.g., "Human, Canine"). This demonstrates an initial intent to capture species metadata, aligning with the "One Health" approach.

### 2. Domain Misalignment in AI Engine
There is a fundamental misalignment between the stated business objectives (precision oncology and cancer markers) and the implemented AI engine prompts. The core system prompt (`ai_engine/llm/prompt_templates.py`) explicitly defines the AI as an assistant for "personalized antimicrobial recommendations" rather than oncological profiling. This discrepancy must be resolved immediately to align the product with the business plan.

### 3. RAG Pipeline Deficiencies
The current Retrieval-Augmented Generation (RAG) pipeline (`ai_engine/llm/rag_pipeline.py`) implements a generic text loader without any metadata tagging or separation by species. If both human and veterinary oncology guidelines are ingested into the same vector database, the LLM is highly likely to hallucinate and conflate treatments. Recommending human drug dosages or therapies for veterinary patients (or vice versa) is a critical safety and liability risk.

### 4. Backend and Data Models
The backend schemas and models (`backend/models`, `backend/schemas`) are currently unpopulated. Furthermore, the core machine learning models (e.g., the JEPA architecture) lack the necessary contextual encoders to differentiate between species-specific genomic variations. A true "One Health" architecture requires robust data modeling that structurally separates and cross-references human and animal genomic data safely.

## Conclusion and Recommendations
The current architecture **does not successfully support** the "One Health" dual-market strategy. To successfully pivot and capture both markets, the following steps are required:

1. **Species-Aware Data Architecture:** Implement strict metadata tagging and namespace separation in the RAG vector store for human vs. veterinary guidelines.
2. **Dynamic Prompting:** Update the AI engine to inject the specific species into the system prompt at runtime, enforcing guardrails against cross-species contamination.
3. **Domain Correction:** Realign the AI prompts and underlying models with the oncology-focused mission outlined in the business plan.
4. **Data Modeling:** Develop robust backend schemas that properly model species, breeds, and species-specific cancer markers.
